Table 4 Results of the one way sensitivity analysis by scenario
Scenarios | ||||
|---|---|---|---|---|
No inflation, no MFF | Inflation, no MFF | No inflation, MFF | Inflation, MFF | |
Admission | £5,531-£12,029 | £5,573-£12,083 | £5,973-£12,991 | £6,019-£13,050 |
Costsa | £6,116-£9,746 | £6,147-£9,796 | £6,606-£10,526 | £6,639-£10,580 |
Intensity of follow-up | £7,133-£7,656 | £7,166-£7,704 | £7,704-£8,269 | £7,739-£8,320 |
Stage at presentation | £7,304-£7,604 | £7,347-£7,650 | £7,888-£8,212 | £7,935-£8,262 |
Lymph node management | £7,368-£7,480 | £7,412-£7,524 | £7,957-£8,078 | £8,005-£8,126 |
Primary tumour management | £7,373-£7,469 | £7,418-£7,513 | £7,963-£8,067 | £8,011-£8,115 |